Edwards Lifesciences Reports First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Edwards Lifesciences (EW) Tops Q1 EPS by 18c, Lowers FY Guidance
April 23, 2020 4:18 PM EDTEdwards Lifesciences (NYSE: EW) reported Q1 EPS of $1.51, $0.18 better than the analyst estimate of $1.33. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.08 billion.
GUIDANCE:
Edwards Lifesciences sees FY2020 EPS of $4.75-$5.25, versus the consensus of $5.10. Edwards Lifesciences sees FY2020 revenue of $4-4.5 billion, versus the consensus of $4.37... More
